Apheresis‐Triggered Torsades De Pointes in Congenital Long QT Syndrome Type 2: Citrate‐Related Arrhythmia Risk and Safe Modality Switching During Myasthenic Crisis
Journal of Clinical Apheresis · 2026
DOI: 10.1002/jca.70185 ↗Kurz gefasst
Fallbericht in der Zeitschrift Journal of Clinical Apheresis, 2026. Verfasst von Masahiro Biyajima und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Japanese Red Cross Nagano Hospital, Nagano, Japan. Hauptthemen laut MEDLINE: Long QT Syndrome, Torsades de Pointes, Myasthenia Gravis, Blood Component Removal. Die Arbeit nennt 6 Literaturangaben.
Abstract (Originalsprache)
Citrate anticoagulation during therapeutic plasma exchange (TPE) chelates divalent cations and can precipitate torsades de pointes (TdP) in patients with pre‐existing repolarization vulnerability. We report a 44‐year‐old woman with genetically determined long QT syndrome Type 2 (LQT2) presenting in myasthenic crisis due to anti‐MuSK‐positive myasthenia gravis. TPE was initiated urgently before confirmatory antibody results were available, as alternative rapid immunomodulatory options were not immediately accessible. Despite prophylactic electrolyte supplementation, the corrected QT interval (QTc) progressively prolonged, rising from a baseline of 493 to 509 ms—exceeding the 500 ms high‐risk threshold—immediately before TdP onset during the second TPE. TPE was discontinued and replaced with double‐filtration plasmapheresis (DFPP) using albumin‐based replacement, which reduces citrate exposure by retaining the patient's own albumin. Five subsequent DFPP sessions were completed without arrhythmia recurrence. This case highlights the apheresis‐related arrhythmia risk in LQT2 and the mechanistic rationale for DFPP as a safer alternative.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Japanese Red Cross Nagano Hospital, Nagano, Japan.
- Department of Nephrology, Japanese Red Cross Nagano Hospital, Nagano, Japan.
ORCID-Profile: Masahiro Biyajima
Zitieren
APA
Biyajima, M., Nakamura, Y., Nagaoka, T., & Tazawa, K. I. (2026). Apheresis‐Triggered Torsades De Pointes in Congenital Long QT Syndrome Type 2: Citrate‐Related Arrhythmia Risk and Safe Modality Switching During Myasthenic Crisis. Journal of Clinical Apheresis. https://doi.org/10.1002/jca.70185
Vancouver
Biyajima M, Nakamura Y, Nagaoka T, Tazawa KI. Apheresis‐Triggered Torsades De Pointes in Congenital Long QT Syndrome Type 2: Citrate‐Related Arrhythmia Risk and Safe Modality Switching During Myasthenic Crisis. Journal of Clinical Apheresis. 2026. doi:10.1002/jca.70185
BibTeX
@article{Biyajima2026,
author = {Biyajima, Masahiro and Nakamura, Yusuke and Nagaoka, Toshihiro and Tazawa, Ko-Ichi},
title = {Apheresis‐Triggered Torsades De Pointes in Congenital Long QT Syndrome Type 2: Citrate‐Related Arrhythmia Risk and Safe Modality Switching During Myasthenic Crisis},
journal = {Journal of Clinical Apheresis},
year = {2026},
doi = {10.1002/jca.70185}
}
EUVIMED